FLRAX
Price
$40.05
Change
-$0.58 (-1.43%)
Updated
Jun 13 closing price
Net Assets
43.9M
VTSAX
Price
$142.91
Change
-$1.69 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82T
Interact to see
Advertisement

FLRAX vs VTSAX

Header iconFLRAX vs VTSAX Comparison
Open Charts FLRAX vs VTSAXBanner chart's image
Nuveen Large Cap Select A
Price$40.05
Change-$0.58 (-1.43%)
VolumeN/A
Net Assets43.9M
Vanguard Total Stock Mkt Idx Adm
Price$142.91
Change-$1.69 (-1.17%)
VolumeN/A
Net Assets1.82T
FLRAX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FLRAX vs. VTSAX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLRAX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.82T vs. FLRAX (43.9M). VTSAX pays higher dividends than FLRAX: VTSAX (1.28) vs FLRAX (0.25). FLRAX was incepted earlier than VTSAX: FLRAX (22 years) vs VTSAX (25 years). FLRAX (1.27) is less costly to investors than VTSAX (0.04). FLRAX is a more actively managed with annual turnover of: 76.00 vs. VTSAX (2.00). FLRAX (3000) and VTSAX (3000) have matching initial minimum investment requirements. VTSAX annual gain was more profitable for investors over the last year : 10.07 vs. FLRAX (-5.77). VTSAX return over 5 years is better than : 91.40 vs. FLRAX (36.04).
FLRAXVTSAXFLRAX / VTSAX
Total Expense Ratio1.010.042,525%
Annual Report Gross Expense Ratio1.270.043,175%
Fund Existence22 years25 years-
Gain YTD-0.4971.365-36%
Front Load6%N/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets43.9M1.82T0%
Annual Yield % from dividends0.251.2819%
Returns for 1 year-5.7710.07-57%
Returns for 3 years37.0757.6164%
Returns for 5 years36.0491.4039%
Returns for 10 years93.81179.5352%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.840.02
+0.71%
GT Biopharma
GMAB22.82-0.27
-1.17%
Genmab A/S ADS
FINW14.36-0.24
-1.64%
FinWise Bancorp
CENT34.21-1.31
-3.69%
Central Garden & Pet Company
CDLX1.51-0.09
-5.63%
Cardlytics